Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents

被引:95
作者
Abadi, AH [1 ]
Hegazy, GH [1 ]
El-Zaher, AA [1 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
关键词
NO-NSAID; quinoline;
D O I
10.1016/j.bmc.2005.05.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Six derivatives of the general formula 2- or 4-(7-trifluoromethylquinolin-4-ylamino) benzoic acid N'-(nitrooxyacetyl or propionyl) hydrazide and an oxime of the formula 1-[4-(7- trifluoromethylquinolin-4-ylamino)phenyl[ethanone oxime were synthesized and tested for their in vivo anti-inflammatory, analgesic, and ulcerogenic properties, as well as their in vitro nitric oxide release ability. Compound 2-(7-trifluoromethylquinolin-4-ylamino)benzoic acid N'-(2-nitrooxy propionyl)hydrazide 12 showed an anti-inflammatory activity comparable to that of indomethacin in the carrageenan-induced rat paw edema test, and equipotency to glafenine in the acetic acid mice induced writhing model at 100 mg/kg p.o., respectively. All the final compounds showed no tendency to induce stomach ulceration in rats; nitric oxide seems to contribute to their excellent safety profile. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5759 / 5765
页数:7
相关论文
共 23 条
  • [1] Abadi AH, 1998, ARCH PHARM, V331, P319, DOI 10.1002/(SICI)1521-4184(199810)331:10<319::AID-ARDP319>3.3.CO
  • [2] 2-M
  • [3] ALLAIS A, 1973, CHIM THER, V8, P154
  • [4] The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: Results from a randomized, controlled trial
    Bias, P
    Buchner, A
    Klesser, B
    Laufer, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (04) : 611 - 618
  • [5] Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin
    Cena, C
    Lolli, ML
    Lazzarato, L
    Guaita, E
    Morini, G
    Coruzzi, G
    McElroy, SP
    Megson, IL
    Fruttero, R
    Gasco, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (05) : 747 - 754
  • [6] The safety of lumiracoxib when used in the treatment of arthritis
    Doggrell, SA
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (02) : 347 - 350
  • [7] Adverse cardiovascular effects of the coxibs
    Dogné, JM
    Supuran, CT
    Pratico, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) : 2251 - 2257
  • [8] Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs:: Defining the role of gastroprotective agents
    Hunt, RH
    Barkun, AN
    Baron, D
    Bombardier, C
    Bursey, FR
    Marshall, JR
    Morgan, DG
    Paré, P
    Thomson, ABR
    Whittaker, S
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 16 (04): : 231 - 240
  • [9] Insel PA, 1996, PHARMACOL BASIS THER, P617
  • [10] Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs
    Keeble, JE
    Moore, PK
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (03) : 295 - 310